Clinical Trials on Prostate Cancer Adenocarcinoma
Total 58304 results
-
Exact ImagingCompletedProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada, United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnStage III Prostate Cancer
-
Consorzio OncotechUnknownProstate Cancer | Castration-resistant Prostate CancerItaly
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...Peking University First Hospital; The Affiliated Nanjing Drum Tower Hospital... and other collaboratorsUnknownStage III Prostate CancerChina
-
AHS Cancer Control AlbertaUnknownHigh-risk Prostate CancerCanada
-
Sergio FariaCompletedHigh Risk Prostate CancerCanada
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Johns Hopkins UniversityCompletedSuspected Primary Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...UnknownHormone Refractory Prostate CancerChina
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
British Columbia Cancer AgencyCompletedHormone Refractory Prostate CancerCanada
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
Poniard PharmaceuticalsUnknownHormone Refractory Prostate CancerRussian Federation
-
Jules Bordet InstituteWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Carcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage III Prostate Cancer AJCC v7 | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States, Ireland
-
Jonsson Comprehensive Cancer CenterTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Stage IV Prostate Cancer American Joint Committee on Cancer (AJCC) v8United States
-
Postgraduate Institute of Medical Education and...RecruitingProstate Cancer | Prostate NeoplasmIndia
-
University College, LondonRecruitingProstate Cancer | Prostate NeoplasmUnited Kingdom
-
Barts & The London NHS TrustTerminatedCastrate Resistant Prostate CancerUnited Kingdom
-
AstraZenecaCompletedCastration-resistant Prostate CancerBrazil, Peru, Mexico, Argentina, Costa Rica, Colombia, Panama
-
Modra PharmaceuticalsThe Netherlands Cancer InstituteCompletedCastration-resistant Prostate CancerNetherlands
-
Taro Iguchi, MD, PHDAstellas Pharma IncCompleted
-
Jiangsu HengRui Medicine Co., Ltd.TerminatedProstate Cancer | Castration-resistant Prostate CancerChina
-
SOTIO a.s.TerminatedCastration-resistant Prostate CancerCzechia
-
Novartis PharmaceuticalsCompletedCastration Resistant Prostate CancerGermany
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate CancerUnited States
-
Novartis PharmaceuticalsCompletedCastration-resistant Prostate CancerFrance, Spain, Canada, Belgium, United Kingdom, United States
-
Momotaro-Gene Inc.The Pacific Link Consulting CoCompletedLocalized Prostate CancerUnited States
-
CelgeneCompletedHormone Refractory Prostate CancerUnited States
-
Bellicum PharmaceuticalsCompletedCastrate Resistent Prostate CancerUnited States
-
Institut Paoli-CalmettesJanssen-Cilag Ltd.UnknownLow Risk Prostate CancerFrance
-
Charles RyanNovartis PharmaceuticalsTerminatedCastrate-resistant Prostate CancerUnited States
-
University Health Network, TorontoCompletedStudy of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerProstatic Neoplasms | Prostate Cancer | Cancer of the ProstateCanada
-
Queen's Medical CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHormone Refractory Prostate CancerUnited States
-
Spanish Oncology Genito-Urinary GroupCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
Daniel George, MDNovartis PharmaceuticalsCompletedHormone Refractory Prostate CancerUnited States
-
University of ChicagoVisualase, Inc.Completed
-
Astellas Pharma IncTerminatedCastrate Resistant Prostate CancerBelgium, France, United Kingdom
-
Veterans Medical Research FoundationUniversity of California, San Diego; Alliant International UniversityCompleted
-
GenVecNational Institutes of Health (NIH)UnknownLocally Advanced Prostate CancerUnited States
-
DendreonCompletedHormone-Refractory Prostate Cancer
-
Medical University of ViennaUnknownHormone Refractory Prostate CancerAustria
-
Sheba Medical CenterUnknownHormone Refractory Prostate CancerIsrael
-
AstraZenecaScandinavian Prostate Cancer GroupCompletedNon-Metastatic Prostate CancerSweden, Finland, Norway, Denmark
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
University of WashingtonJanssen Scientific Affairs, LLCRecruitingCastration-Resistant Prostate Carcinoma | Prostate AdenocarcinomaUnited States